期刊文献+

自拟沙参麦冬鳞癌方治疗晚期肺鳞癌(气阴两虚型)60例临床疗效观察 被引量:7

Advanced Lung Squamous Cell Carcinoma Treated by Self-Made Shashen Maidong Lin'ai Formula: A Clinical Observation of 60 Cases of the Pattern of Qi-Deficiency and Yin-Deficiency
下载PDF
导出
摘要 目的:观察沙参麦冬鳞癌方对晚期肺鳞癌患者(气阴两虚型)的临床治疗效果。方法:将晚期肺鳞癌患者(辨证属气阴两虚型)60例随机均分为两组,对照组予以对症治疗(呕吐者予以护胃止呕药物;粒细胞减少者予以升粒细胞药物;内环境紊乱者予纠正水电解质代谢、酸碱平衡等);治疗组在与对照组治疗方法相同的前提下,加用沙参麦冬鳞癌方。结果:(1)经治疗,两组各个临床观察指标(中医症候积分、近期客观疗效、KPS评分、血清CEA水平)变化情况均有统计学差异(P<0.05),对照组不及治疗组;(2)两组不良反应发生差异无统计学意义(P>0.05)。结论:沙参麦冬鳞癌方对治疗气阴两虚型的晚期肺鳞癌患者可取得较好疗效,无明显不良反应。 Objective: To observe the clinical effect of Shashen Maidong Lin'ai Formula on advanced lung squamous cell carcinoma of qi -deficiency and yin -deficiency. Methods: 60 patients with advanced lung squamous cell carcinoma of qi -deficiency and yin -deficiency were randomly divided into the control group and the treatment group. The control group was treated with general symptomatic treatment;on which basis, the treatment group was also treated with Shashen Maidong Lin'ai Formula. The treatment course was three months. Results: After the treatment, the treatment group was better than the control group in terms of improving TCM symptom scores, KPS scores, short-term objective effects, and serum level of CEA( P <0.05). There was no statistical difference in adverse reactions between the two groups( P >0.05). Conclusion: Shashen Maidong Lin'ai Formula can effectively treat advanced lung squamous cell carcinoma of the qi -deficiency and yin -deficiency, without obvious adverse reactions.
作者 敖群霞 曾柏荣 AO Qunxia;ZENG Bairong(Hunan University of Chinese Medicine,Changsha 410208,China;The First Affiliated Hospital of Hunan University of Chinese Medicine,Changsha 410007,China)
出处 《中医药学报》 CAS 2019年第2期88-90,共3页 Acta Chinese Medicine and Pharmacology
关键词 沙参麦冬鳞癌方 晚期肺鳞癌 气阴两虚型 Shashen Maidong Lin'ai Formula Advanced lung squamous cell carcinoma Pattern of qi -deficiency and yin -deficiency
  • 相关文献

参考文献4

二级参考文献62

  • 1叶榕,林久茂,魏丽慧,庄群川,赵锦燕,彭军.白花蛇舌草乙醇提取物对人结肠癌HT-29细胞增殖及Hedgehog信号传导通路表达的影响[J].海峡科学,2012(8):100-102. 被引量:6
  • 2林久茂,詹友知,魏丽慧,王佳宝,陈瑞花,刘丽琼,李煌,彭军.白花蛇舌草提取物逆转结肠癌细胞5-Fu耐药的作用[J].福建中医药,2013,44(1):53-55. 被引量:21
  • 3周际昌.实用中医内科学[M].第2版.北京:人民卫生出版社,2003:47-48.
  • 4王三虎,王宗仁,冯献斌,范先基,李俊,张定进,石彧,王志祥.润肺散结胶囊治疗气阴两虚痰浊泛肺型非小细胞肺癌临床研究[J].中国中医急症,2007,16(10):1185-1186. 被引量:5
  • 5Bruening A. Inhibition of mTOR signaling by quercetin in cancertreatment and prevention [J]. Anticancer Agents Med Chem,2013, 13 (7): 1025-1031.
  • 6Gu Guowei,Barone I,Gelsomino L,et al. Oldenlandia diffusaextracts exert antiproliferative and apoptotic effects on human breastcancer cells through ERa /Spl-mediated p53 activation [J]. J CellPhysiol, 2012, 227 (10): 3363-3372.
  • 7SONG YH, Jeong SJ, Kwon HY, et al. Ursolic acid fromoldenlandia diffusa induces apoptosis via activation of caspases andphosphorylation of glycogen synthase kinase 3 beta in SK-OV-3ovarian cancer cells [J]. Biol Pharm Bull, 2012, 35 (7) : 1022-1028.
  • 8LIU Z,LIU M, LIU M, et al. Methylanthraquinone from Hedyotisdiffusa WILLD induces Ca^-mediated apoptosis in human breastcancer cells[ j]. Toxicol In Vitro, 2010 , 24 (1): 142-147.
  • 9WANG JH, SHU LH, YANG LL, et al. 2-Hydroxy-3-methylanthraquinone from Hedyotis diffusa WILLD induces apoptosisvia alteration of Fas/FasL and activation of caspase-8 in humanleukemic THP-1 cells [J]. Arch Med Res, 2011,42 (7):577-583.
  • 10WANG N, LI DY, NIU HY, et al. 2-Hydroxy-3-methylanthraquinone from Hedyotis diffusa Willd induces apoptosisin human leukemic U937 cells through modulation of MAPKpathways [ J ]. Arch Pharm Res, 2013,36 (6): 752—758.

共引文献79

同被引文献117

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部